DURECT Corp
NASDAQ:DRRX

Watchlist Manager
DURECT Corp Logo
DURECT Corp
NASDAQ:DRRX
Watchlist
Price: 1.26 USD -2.33% Market Closed
Market Cap: 39.1m USD
Have any thoughts about
DURECT Corp?
Write Note

DURECT Corp
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DURECT Corp
Research & Development Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
DURECT Corp
NASDAQ:DRRX
Research & Development
-$19.2m
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
1%
Johnson & Johnson
NYSE:JNJ
Research & Development
-$16.4B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Research & Development
-$9.3B
CAGR 3-Years
1%
CAGR 5-Years
-13%
CAGR 10-Years
-10%
Pfizer Inc
NYSE:PFE
Research & Development
-$10.6B
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Research & Development
-$19B
CAGR 3-Years
-20%
CAGR 5-Years
-18%
CAGR 10-Years
-11%
Eli Lilly and Co
NYSE:LLY
Research & Development
-$10.2B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-7%

See Also

What is DURECT Corp's Research & Development?
Research & Development
-19.2m USD

Based on the financial report for Jun 30, 2024, DURECT Corp's Research & Development amounts to -19.2m USD.

What is DURECT Corp's Research & Development growth rate?
Research & Development CAGR 10Y
1%

Over the last year, the Research & Development growth was 47%. The average annual Research & Development growth rates for DURECT Corp have been 13% over the past three years , 5% over the past five years , and 1% over the past ten years .

Back to Top